Team Leader
Prof. Dr. Paolo Caraceni
Team Staff
Dr. Agnese Antognoli
Institute Presentation
The University of Bologna (UNIBO), created in the year 1088, is recognized ad the oldest university in the western world, and one the largest in Italy (with more than 85 000 enrolled students per year). The Unit of Semeiotica Medica is part of the UNIBO Department of Medical and Surgical Sciences within the University Hospital “Azienda Ospedaliero Universitaria Sant’Orsola – Malpighi” Polyclinic (AOSP). The main tasks of this structure are the management and prevention of complications of cirrhosis while the research activity of the unit is devoted to preclinical, translational, and clinical research in the field of complications of cirrhosis to optimize management and prevention of decompensation and acute-on-chronic liver failure (ACLF).
Within the DECISION project, UNIBO is the leader of WP5. In particular, UNIBO will contribute to the selection of the combinatorial therapy derived from the preclinical validation, and be responsible for the design, conduction, and coordination of the clinical trial in close collaboration with EF CLIF. Moreover, the PI Prof. Caraceni will lead the Clinical Trial Management Committee (CTMC) with the aim to coordinate and supervise the clinical trial.